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Objective: Very little is known about car driving in palliative patients. We have asked patients in at home palliative
care environments about their driving habits during palliative care.
Methods: At admittance to the palliative care program and at regular visits the patients were asked a few
questions about age, diagnosis, sex, driving license, driving, medication and functional status.
Results: 23% (40) of our studied patients (173) were still driving, and if we included patients who responded that
they would still consider driving, the corresponding figure was 39%.
Conclusions: Our study indicates that the prescribing doctor should be well informed about national driving
legislation and be prepared to discuss driving in combination with heavy opioid medication and tranquilizers even
with patients in palliative care.Introduction
Quality of life is important for patients who are suffering
from life-threatening diseases and their families. In pal-
liative care, symptom relief, teamwork, communication
and attention to relatives/carer are important aspects of
helping patients maintain their dignity and well-being.
Palliative care is often introduced in end-of-life care, in
order to attend to these patients’ physical, psychological,
social and existential needs. Although studies are increas-
ingly being done on this patient group, there are still
concerns that have not been addressed.
We know that car driving is important to the lives of
most people in Sweden, but we do not know how common
driving is among our palliative patients. How does their
palliative status affect their driving? How many patients in
palliative care still drive? What medications do they take?
Is there a sex role difference? How important is it to these
patients to retain their drivers’ licenses? Being able to drive
is one aspect of maintaining integrity, giving the patients
some freedom despite a life-threatening disease. Having a
car is also often part of the patient’s being able to stay at
home despite the disease.
A literature search for studies on palliative care and
driving turned up no hits.
To our knowledge this is the first study on this topic.
The present paper describes car driving habits during
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The palliative care team in the county of Gävleborg
serves patients in urban and rural areas. The county is
just over 4,000 km2 and is located in central Sweden.
The palliative team sees patients on heavy medication,
such as opioids and tranquilizers.
Our routine is to accept patients primarily with cancer
diagnoses and living in their own homes, sometimes
supported by family, friends, home care and local nurses.
We see the patients at home by agreement, usually once
every three or four weeks, and by need, and we are in
close contact by telephone. The patients are mainly
referred to palliative care from departments of oncology,
internal medicine (mainly with lung cancer), surgery
and gynecology. The patients are almost always handed
over to the palliative care team by their referring doctor,
including GP:s, after referral.
During one year we have approximately 200 deaths
among our approximately 300 referred patients per year,
and a mean survival time of 3–4 months, with large vari-
ations. The difference consists of patients actually not
coming to their homes again, dying before enrollment
and a slow increase in patient survival time.
For this study we asked 200 consecutive patients, both
new patients at the introductory appointment and existing
patients at follow-up appointments to answer a question-
naire about their driving habits. Those who responded
that they were still driving were asked to fill out the
questionnaire again at the next appointment. The studyger. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Table 2 Age and sex of patients in study
Men Women
Number (n) 90 83
Mean 75 y 74 y
Median 77 (46–91 y) 76 (41–94 y)
No drivers’ license (n) 5 (6%) 25 (31%)
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included on March 1, 2012. The study was completed at
the end of April 2012. The study was approved by the
Ethics Committee at Uppsala University (Dnr 2011/098).
The inquiry consisted of questions about age, diagnosis,
sex, driving license, driving, medication and performance
status. The questionnaire was discussed and filled in
by patient, often with comments from relatives at our
regular visits.Results
Of the 200 patients initially asked, 27 were not included
in the study for various reasons such as poor mastery of
Swedish, dementia, too poor performance status to be
asked again or imminently death. Only one person did
not agree to participate in the study.
The most common diagnoses are listed in Table 1. Note
that in the lung cancer and breast cancer groups there
were no patients who were still driving.
A total of 173 patients were included, 90 men and 83
women (Table 2).
Forty (23%) patients, of whom seven were women,
initially said that they were still driving. The mean age
was 65.6 years for the women and 71 years for the men.
Another group of 27 patients (10 women) still considered
driving an option although they did not exercise it
(Table 3).
These groups of actual and potential drivers accounted
for 39% of all included patients. We later found out that
9 patients (4 women) had said they were still driving
were actually not, according to later information from
their relatives, friends, home care and local nurses.
Of the 52 men who said they were not driving, 27 had
driven during 2011 prior to study entrance. The corre-
sponding figure for women was 15 out of 50.
Almost all the patients with a drivers’ license considered
it important to keep their licenses for reasons ranging
from identification, to hope, to emergencies. The patients
in our study who had drivers’ licenses had had them for a
long time: 24–73 years (median 50 years).
Performance status (WHO) was significantly better
among drivers than non-drivers (Table 4).Table 1 Diagnoses of the patients in the study
Diagnosis Total (n) Drivers
Prostate cancer 25 12
Lung cancer 23 0
Colon cancer 23 7
Rectal cancer 12 6
Pancreatic cancer 12 3
Breast cancer 11 0Of the patients who did not drive during the study,
43% died during this study period. The corresponding
figure for participants who were still driving was 48%.
With regard to driving frequency, 13 patients responded
that they were still driving daily and 20 others that they
were still driving 1–4 times per week. A few who were still
driving drove less frequently. There were no differences
between those living in urban and rural areas. Of the 40
patients still driving, 17 said they had no one to help them
with their driving needs, and no participants used the
transportation services for the disabled.
In the group who were still driving 26(65%) were on
opioids in form of fentanyl-patch, oxycodone and long-
acting morphine. Doses varied from 24 to 250 ug of
fentanyl (oral morphine 60–860 mg), oxycodone 10 to
80 mg (oral morphine 20–160 mg) and long-acting
morphine 20 to 120 mg (Table 5).
Antidepressants were in use among 33% of driving
patients. Eight (20%) were on medication for insomnia
and 13 (33%) were on sedatives either regularly or when
needed (Table 5). Seven of the driving patients were on no
medication at all.
Discussion
Swedish driving legislation says that it is not allowed to
drive using medicine classified as narcotics if it is not
prescribed by doctors and if you can not handle ordinary
traffic situations safe. That is also true for other medication.
In this investigation, we found no previous studies
concerning car driving and palliative care patients. We
found that none of our patients with a diagnosis of lung
cancer or breast cancer were still driving. Patients with
these diagnoses had higher performance status (WHO)
than average, probably owing to late remittance and long
cancer treatment.
Non-inclusion was as expected, owing to cultural
problems, dementia, and patients too ill to be included,
i.e. with death imminent, which correlates to our previousTable 3 Patients still driving and patients considering
driving still an option
Men Women
Drivers (n) 33 7
Mean age 71 y 65.6 y
Consider driving an option (n) 17 10




Performance status (WHO) for our patients outside the study two
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liative care patients die within one month. Since our
follow-up was only at three to four week intervals, this
made it impossible to follow the development of driving
habits in this patient group.
Most of the men and women in our study had a drivers’
license and intended to keep it, considering it related to
their integrity. The women in our driving group seemed
to be more cautious and had better performance status.
Having reasonable performance status does, however, not
preclude rapid changes, and 48% of the drivers died during
the study. This is an indication that there is often a short
time lag between driving and non-driving.
We also have indications that patients’ performance
status and even their ability to drive may improve after
being included in palliative care. This may be due to
stopping cytostatic treatment or other interventions which
are known to be fatiguing. Performance status was better,
measured when included in the study than at inclusion in
routine palliative care outside the study (Table 4).
Medication status was very similar between drivers
and non-drivers, and between men and women. Studies
concerning effects on driving ability while on strong
pain killers, antidepressants and sedatives are sparse.
There are very few such concerning cancer patients
and none concerning palliative care patients. There are
indications that stable medication with opioids and
antidepressants does not affect driving ability (Vainio
et al. 1995; Wingen et al. 2005). Such studies mainly seem
to have been made on subjects without life-threatening
diseases. Most patients who are prescribed sedatives to be






Morphine if needed 5
Antidepressants 33%
Hypnotics 20%while still driving, but there are to our knowledge, no such
studies concerning patients on palliative care, (Vainio
et al. 1995; Wingen et al. 2005; Johansson 2011/2012).
Our driving patients lived both in urban and rural
areas and half of the drivers said they would have had
no one else to help them with driving if they stopped.
One group of patients with drivers’ licenses had made
a definite personal decision not to go on driving, and they
were often able to state exactly when they had made this
decision, and why. Poor general health status was often
mentioned. We could also see that one group of our
patients who considered themselves drivers were actually
in the process of losing their autonomy, although they had
not yet acknowledged it.
No accidents came to our attention, but one male patient
was reported to the authorities for not agreeing to stop
driving although he had been instructed by the doctor to
stop. He turned out to have brain metastases.
Clinical implications
We found driving to remain important, even for patients
in palliative care, a fact which is useful to know in clinical
practice. Continuing to drive is one aspect of maintaining
hope, a feeling shared by patients in palliative care. The
individual’s performance status is important in relation
to his or her ability to drive safely and can change rapidly.
Our team tries to recommend our patients to avoid driv-
ing feeling fatigue. Doctors who see these patients should
be familiar with driving legislation in their country in
order to be able to advise their palliative patients in
the best manner possible. They should also learn about
conclusions drawn from research in this field and find
compilations for local conditions, as in Sweden (Johansson
2011/2012). If available they could use written patient
information (Patient information 2009).
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